Recent failures of new potential symptomatic treatments for Parkinson's disease: causes and solutions.

@article{Linazasoro2004RecentFO,
  title={Recent failures of new potential symptomatic treatments for Parkinson's disease: causes and solutions.},
  author={Gurutz J Linazasoro},
  journal={Movement disorders : official journal of the Movement Disorder Society},
  year={2004},
  volume={19 7},
  pages={743-754}
}
One major goal of current research in Parkinson's disease (PD) is the discovery of novel agents to improve symptomatic management. The object of these new treatments should be to provide effective symptom control throughout the course of the disease without the development of side effects such as motor and psychiatric complications. Results of several clinical trials of new treatment options reported in the past 2 years have shown negative or unsatisfactory results. Most of the drugs and… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.

Cold Spring Harbor perspectives in medicine • 2012
View 1 Excerpt

Experimental Models of l-DOPA-Induced Dyskinesia.

International review of neurobiology • 2011
View 2 Excerpts

Pedunculopontine stimulation from primate to patient

Journal of Neural Transmission • 2011
View 1 Excerpt

Dopamine receptor pharmacology.

Handbook of clinical neurology • 2007
View 1 Excerpt

Similar Papers

Loading similar papers…